NALOXONE HCI

Product NDC
51662-1242
11-digit product format
516621242
Labeler code
51662
Product ID
51662-1242_0ff862db-44cb-aac2-e063-6394a90a8a5d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
NALOXONE HCI
Dosage form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Labeler
HF Acquisition Co. LLC, DBA Health First
Application
ANDA070256
Marketing category
ANDA
Marketing start
2018-08-18
Substance
NALOXONE HYDROCHLORIDE
Active strength
.4 mg/mL
Pharmacologic classes
Opioid Antagonist [EPC], Opioid Antagonists [MoA]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
NALOXONE HCI
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
NALOXONE HYDROCHLORIDE.4 mg/mL

Harmonized Identifiers#

Field, Values table
FieldValues
UniiF850569PQR
Rxcui1659929

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c955d208-c333-9bd7-be34-d7e12986d44eProduct name620250626
e5f98bfa-66d5-4c3a-b22d-9543d3bee304Product name120250204
caa6391e-3db3-c912-335f-61b5fc00aa12Product name920240110
65a3bc34-04ff-4cf1-aad9-c7d92a062f6dProduct name120231003
e951cdf3-f269-4d97-a7d5-c1c3d7283a7dProduct name320230313
ab841ac7-728a-4fc9-be0a-35b96cecbf39Product name420230306
f327b80c-8fa2-404b-838a-df3eec141cf2Product name120221212
d4aa2fcf-79c3-4b5f-a00e-1a8e26e00119Product name120220511
b871fccd-1de6-4c7f-b9e5-045304641ee6Product name820220118
43b1efe2-1425-4b3e-b3a2-57d40f8478b9Product name120211026
4c23a34c-e8fc-424c-8fa0-ee064ba6eaefProduct name120170706
0b8c7273-1da3-495f-909a-7cf1e96d2361Product name120161212
3df867ed-9d48-45cf-bded-1394beaea0b1Product name320161206
8a245632-e24f-4ccc-b671-995d89c96ebcProduct name120141203

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
51662-1242-1NALOXONE HCI1 mL in 1 VIALINJECTION, SOLUTION19
51662-1242-2NALOXONE HCI1 mL in 1 POUCHINJECTION, SOLUTION19
51662-1242-3NALOXONE HCI50 in 1 CASEINJECTION, SOLUTION509

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
51662-1242NALOXONE HCI INJECTION, SOLUTION [HF ACQUISITION CO. LLC, DBA HEALTH FIRST]9Current NDC, Legacy NDC, 3 package rows20240128_73c1bad3-6ac3-8682-e053-2a91aa0a176a.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1659929naloxone HCl 0.4 MG in 1 ML InjectionPSN73c1bad3-6ac3-8682-e053-2a91aa0a176a9
16599291 ML naloxone hydrochloride 0.4 MG/ML InjectionSCD73c1bad3-6ac3-8682-e053-2a91aa0a176a9
1659929naloxone HCl 0.4 MG per 1 ML InjectionSY73c1bad3-6ac3-8682-e053-2a91aa0a176a9

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
51662-1242-1516621242011 mL in 1 VIAL (51662-1242-1) 1 ml2018-08-180000-00-00NoNoCurrent
51662-1242-2516621242021 mL in 1 POUCH1 mlHistorical
51662-1242-35166212420350 POUCH in 1 CASE (51662-1242-3) / 1 mL in 1 POUCH (51662-1242-2) 50 pouch2020-06-150000-00-00NoNoCurrent